FDA Consolidates Drug Regulations in Response to REGO Initiative

Summary

The Food and Drug Administration (FDA) is streamlining its drug regulations by consolidating them into a single section, eliminating redundant sections, and removing certain information, in an effort to make the regulations more concise and efficient, in accordance with the President's regulatory reinvention initiative (REGO).